Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Verona Pharma

23 Oct 2020 17:30

RNS Number : 0995D
FTSE Russell
23 October 2020
 

 

 

 

 

Verona Pharma (UK): Constituent DeletionChanges in FTSE UK Index Series

23 October 2020

Subject to the expected cancellation of trading on AIM for Verona Pharma (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

30 October 2020

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSXXLFLBBLEFBK
Date   Source Headline
18th May 20152:36 pmRNSDirector/PDMR Shareholding
13th May 20157:00 amRNS2014 Annual Report and Accounts and Notice of AGM
12th May 20157:00 amPRNFinal Results
5th May 20153:01 pmPRNNotice of Results
14th Apr 20157:00 amPRNPresentation at the Asthma and COPD Conference
23rd Mar 20157:00 amPRNInterim results from new RPL554 trial
3rd Mar 20153:32 pmPRNDirector’s Dealing
3rd Mar 20157:00 amPRNTrading and Development Programme Update
16th Feb 201511:29 amPRNDirector’s Dealing
16th Feb 20157:00 amRNSDirector's Dealing
5th Feb 201510:29 amPRNDirector’s Dealing
30th Jan 20152:46 pmPRNGrant of Share Options
20th Jan 20159:32 amPRNDirector’s Dealing
14th Jan 20157:00 amPRNDirector's Dealing
12th Jan 20157:01 amPRNPresentation at 7th Annual Biotech Showcase™
12th Jan 20157:00 amPRNFirst patients dosed with new formulation of RPL554
17th Dec 20147:00 amPRNCMO appointment & incorporation of Verona Pharma Inc
5th Dec 20149:47 amPRNDirector Dealings
25th Nov 20141:56 pmRNSDirector's Dealing
24th Nov 20147:00 amPRNDr David Ebsworth Appointed as Non-Executive Chairman
11th Nov 201412:12 pmPRNGrant of Share Options
3rd Nov 20147:00 amPRNCF Trust Venture and Innovation Award
30th Sep 20147:00 amPRNAppointment of Biresh Roy as CFO and Board member
29th Sep 20147:00 amPRNNew data supports RPL554 as a potential CF therapy
11th Sep 20147:00 amPRNHalf-yearly Report
9th Sep 20147:00 amPRNERS Presentations
4th Sep 20147:00 amPRNNotice of Results
6th Aug 201411:57 amPRNAppointment of Nominated Adviser and Broker
2nd Jul 201412:48 pmPRNAmendment - Director Shareholding
2nd Jul 20149:35 amPRNDirector Shareholding
23rd Jun 20147:00 amPRNPhase IIa headline results for VRP700
12th Jun 201411:26 amPRNResult of AGM
21st May 20147:00 amPRNPoster Presentation at ATS
19th May 20143:53 pmPRNPosting of Annual Report and AGM Notice
16th May 201411:25 amPRNGrant of Share Options
28th Apr 20147:00 amPRNFinal Results
24th Apr 20147:00 amPRNChange in Registered Office
1st Apr 20147:00 amPRNNotice of Results
27th Mar 201412:27 pmPRNHolding(s) in Company
27th Mar 201412:24 pmPRNHolding(s) in Company
26th Mar 20141:36 pmPRNHolding(s) in Company
26th Mar 20141:35 pmPRNHolding(s) in Company
26th Mar 20141:33 pmPRNHolding(s) in Company
26th Mar 20141:24 pmPRNHolding(s) in Company
24th Mar 20142:12 pmPRNResult of General Meeting
24th Mar 20147:00 amPRNResult of Open Offer
6th Mar 20145:53 pmPRN£13m Equity Issue, £1m Open Offer and Notice of GM
13th Nov 20137:00 amPRNPresentation at Therapeutic Area Partnerships Meeting
30th Oct 20135:36 pmPRNHolding(s) in Company
25th Oct 20137:00 amPRNRPL554 clinical studies published in The Lancet RM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.